Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Clinical trial NCT00140478 · COMPLETED

Trial details

NCT number: NCT00140478
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Adenocarcinoma of Prostate

Start date: 2005-02-01
Primary completion: 2006-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.